Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Molecular Templates Inc (MTEM)

Molecular Templates Inc (MTEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 17
  • Shares Outstanding, K 6,584
  • Annual Sales, $ 57,310 K
  • Annual Income, $ -8,120 K
  • EBIT $ -19 M
  • EBITDA $ -12 M
  • 60-Month Beta 1.25
  • Price/Sales 0.03
  • Price/Cash Flow N/A
  • Price/Book 0.00
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.70
  • Most Recent Earnings $-1.23 on 08/14/24
  • Next Earnings Date 01/06/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0001 +100.00%
on 01/21/25
0.1600 -99.88%
on 12/23/24
-0.1598 (-99.88%)
since 12/20/24
3-Month
0.0001 +100.00%
on 01/21/25
1.1300 -99.98%
on 11/14/24
-0.7498 (-99.97%)
since 10/21/24
52-Week
0.0001 +100.00%
on 01/21/25
4.1200 -100.00%
on 03/04/24
-3.7245 (-99.99%)
since 01/19/24

Most Recent Stories

More News
Molecular Templates, Inc. Faces Delisting from Nasdaq Due to Compliance Issues

Molecular Templates faces delisting from Nasdaq due to non-compliance and plans to suspend trading on December 26, 2024.Quiver AI SummaryMolecular Templates, Inc., a clinical-stage biopharmaceutical company...

MTEM : 0.0002 (-92.31%)
Molecular Templates Announces Notice of Delisting and Failure to Satisfy Continued Listing Rules

MTEM : 0.0002 (-92.31%)
Molecular Templates, Inc. Receives Nasdaq Deficiency Notification for Reporting and Bid Price Compliance

Molecular Templates received Nasdaq deficiency notices for late filings and failing to maintain minimum bid price.Quiver AI SummaryMolecular Templates, Inc. has received a notification from Nasdaq indicating...

MTEM : 0.0002 (-92.31%)
Molecular Templates Announces Receipt of Expected Notification of Deficiency from Nasdaq Related to Delayed filing of Quarterly Report on Form 10-Q and Failure to Meet Bid Price Requirements

MTEM : 0.0002 (-92.31%)
Stocks Set to Open Lower as Investors Await FOMC Minutes, Inflation Data

June S&P 500 futures (ESM23) are down -0.21%, and June Nasdaq 100 E-Mini futures (NQM23) are down -0.34% this morning as market participants assessed recent labor market data while awaiting the release...

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
JPM : 263.03 (+1.49%)
WFC : 77.85 (+1.00%)
C : 81.67 (+2.10%)
PXD : 269.62 (+0.73%)
FRC : 3.51 (-43.30%)
SQ : 86.96 (+0.67%)
MTEM : 0.0002 (-92.31%)
NTAP : 123.67 (+1.29%)
RBBN : 4.14 (+2.73%)
Molecular Templates to Present at Upcoming Investor Conferences

AUSTIN, Texas, May 17, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

MTEM : 0.0002 (-92.31%)
Molecular Templates, Inc. Reports First Quarter 2022 Financial Results

AUSTIN, Texas, May 12, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

MTEM : 0.0002 (-92.31%)
Molecular Templates’ Presentations at the American Association of Cancer Research (AACR) Annual Meeting 2022 Highlight Potential of ETB Approach

Presentations from multiple pipeline programs feature clinical and preclinical data demonstrating the unique biology of Molecular Templates’ technology...

MTEM : 0.0002 (-92.31%)
Molecular Templates to Host Webinar on a Unique Approach to Immuno-Oncology for Solid Tumors

Event will feature a presentation by David Spigel, MD, chief scientific officer of the Sarah Cannon Research Institute Wednesday, April 13th @ 8:00 am...

MTEM : 0.0002 (-92.31%)
Molecular Templates, Inc. Reports Fourth Quarter 2021 Financial Results

AUSTIN, Texas, March 28, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

MTEM : 0.0002 (-92.31%)

Business Summary

Molecular Templates Inc. is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies for the treatment of cancers and other serious diseases. Molecular Templates Inc., formerly known as Threshold Pharmaceuticals Inc., is headquartered...

See More

Key Turning Points

3rd Resistance Point 0.0003
2nd Resistance Point 0.0003
1st Resistance Point 0.0002
Last Price 0.0002
1st Support Level 0.0001
2nd Support Level 0.0001
3rd Support Level 0.0000

See More

52-Week High 4.1200
Fibonacci 61.8% 2.5462
Fibonacci 50% 2.0601
Fibonacci 38.2% 1.5739
Last Price 0.0002
52-Week Low 0.0001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar